$2.86 Billion is the total value of Boxer Capital, LLC's 88 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 34.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | MIRATI THERAPEUTICS INC | $353,820,000 | +9.5% | 2,000,000 | 0.0% | 12.36% | +8.4% | |
| BGNE | BEIGENE LTDsponsored adr | $277,400,000 | +5.8% | 764,188 | 0.0% | 9.69% | +4.7% | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | $131,695,000 | -23.0% | 2,075,905 | 0.0% | 4.60% | -23.8% | |
| ITOS | ITEOS THERAPEUTICS INC | $117,315,000 | +5.3% | 4,345,016 | 0.0% | 4.10% | +4.2% | |
| New | TYRA BIOSCIENCES INC | $111,228,000 | – | 6,323,359 | +100.0% | 3.88% | – | |
| RVMD | REVOLUTION MEDICINES INC | $95,852,000 | -13.3% | 3,484,264 | 0.0% | 3.35% | -14.2% | |
| New | TANGO THERAPEUTICS INC | $88,850,000 | – | 6,871,642 | +100.0% | 3.10% | – | |
| CYTK | CYTOKINETICS INC | $75,054,000 | +80.6% | 2,100,000 | 0.0% | 2.62% | +78.8% | |
| RCUS | ARCUS BIOSCIENCES INC | $72,700,000 | +27.0% | 2,084,883 | 0.0% | 2.54% | +25.7% | |
| PMVP | PMV PHARMACEUTICALS INC | $67,593,000 | -12.8% | 2,268,236 | 0.0% | 2.36% | -13.7% | |
| IDYA | IDEAYA BIOSCIENCES INC | $56,150,000 | +21.4% | 2,202,812 | 0.0% | 1.96% | +20.2% | |
| ARGX | ARGENX SEsponsored adr | $51,620,000 | +0.3% | 170,926 | 0.0% | 1.80% | -0.7% | |
| CNTB | CONNECT BIOPHARMA HLDGS LTDads | $50,430,000 | +24.1% | 2,081,323 | 0.0% | 1.76% | +22.8% | |
| SAGE | SAGE THERAPEUTICS INC | $48,475,000 | -22.0% | 1,094,000 | 0.0% | 1.69% | -22.8% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $43,820,000 | -32.5% | 1,466,051 | 0.0% | 1.53% | -33.2% | |
| SNDX | SYNDAX PHARMACEUTICALS INC | $43,720,000 | +11.3% | 2,287,782 | 0.0% | 1.53% | +10.2% | |
| BPMC | New | BLUEPRINT MEDICINES CORP | $43,694,000 | – | 425,000 | +100.0% | 1.53% | – |
| NUVB | NUVATION BIO INC | $43,150,000 | +6.8% | 4,341,009 | 0.0% | 1.51% | +5.7% | |
| KNTE | Buy | KINNATE BIOPHARMA INC | $42,531,000 | +71.4% | 1,847,559 | +73.3% | 1.48% | +69.5% |
| MRUS | MERUS N V | $41,800,000 | +4.4% | 1,900,000 | 0.0% | 1.46% | +3.4% | |
| RLAY | RELAY THERAPEUTICS INC | $40,804,000 | -13.8% | 1,294,132 | 0.0% | 1.42% | -14.7% | |
| DBVT | DBV TECHNOLOGIES S Asponsored adr | $36,920,000 | -10.4% | 7,534,598 | 0.0% | 1.29% | -11.3% | |
| NRIX | NURIX THERAPEUTICS INC | $36,698,000 | +12.9% | 1,224,892 | 0.0% | 1.28% | +11.8% | |
| FULC | New | FULCRUM THERAPEUTICS INC | $35,263,000 | – | 1,250,000 | +100.0% | 1.23% | – |
| ANAB | ANAPTYSBIO INC | $35,256,000 | +4.6% | 1,300,000 | 0.0% | 1.23% | +3.5% | |
| TPTX | New | TURNING POINT THERAPEUTICS INC | $34,876,000 | – | 525,000 | +100.0% | 1.22% | – |
| GOSS | Sell | GOSSAMER BIO INC | $30,952,000 | +48.8% | 2,462,358 | -3.9% | 1.08% | +47.3% |
| DAWN | DAY ONE BIOPHARMACEUTICALS INC | $28,237,000 | +4.2% | 1,189,943 | 0.0% | 0.99% | +3.1% | |
| RNA | AVIDITY BIOSCIENCES INC | $27,618,000 | -0.3% | 1,121,327 | 0.0% | 0.96% | -1.4% | |
| MARINUS PHARMACEUTICALS INC | $27,312,000 | -36.6% | 2,400,000 | 0.0% | 0.95% | -37.2% | ||
| New | NUVALENT INC | $27,290,000 | – | 1,210,192 | +100.0% | 0.95% | – | |
| IOVA | New | IOVANCE BIOTHERAPETUICS INC | $27,126,000 | – | 1,100,000 | +100.0% | 0.95% | – |
| BMEA | BIOMEA FUSION INC | $24,998,000 | -23.3% | 2,088,405 | 0.0% | 0.87% | -24.1% | |
| CGEM | CULLINAN ONCOLOGY INC | $24,242,000 | -12.4% | 1,074,082 | 0.0% | 0.85% | -13.2% | |
| ALGS | ALIGOS THERAPEUTICS | $23,669,000 | -23.9% | 1,526,048 | 0.0% | 0.83% | -24.7% | |
| GHRS | GH RESEARCH PLCordinary shares | $22,356,000 | +1.5% | 1,013,399 | 0.0% | 0.78% | +0.5% | |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $22,282,000 | +10.9% | 1,334,227 | +47.6% | 0.78% | +9.7% |
| FOLD | AMICUS THERAPEUTICS INC | $22,204,000 | -0.9% | 2,325,000 | 0.0% | 0.78% | -2.0% | |
| PRTA | New | PROTHENA CORP PLC | $21,369,000 | – | 300,000 | +100.0% | 0.75% | – |
| BCAB | BIOATLA INC | $20,206,000 | -30.5% | 686,347 | 0.0% | 0.71% | -31.2% | |
| KURA | KURA ONCOLOGY INC. | $19,672,000 | -10.2% | 1,050,289 | 0.0% | 0.69% | -11.1% | |
| CABA | CABALETTA BIO INC | $19,497,000 | +41.4% | 1,603,361 | 0.0% | 0.68% | +40.1% | |
| PASG | PASSAGE BIO INC | $19,206,000 | -24.8% | 1,928,315 | 0.0% | 0.67% | -25.5% | |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $19,225,000 | – | 2,500,000 | +100.0% | 0.67% | – |
| AKRO | AKERO THERAPEUTICS INC | $18,584,000 | -9.9% | 831,495 | 0.0% | 0.65% | -10.9% | |
| BLU | BELLUS HEALTH INC | $18,267,000 | +97.4% | 2,975,000 | 0.0% | 0.64% | +95.7% | |
| RAIN | RAIN THERAPEUTICS INC | $17,578,000 | -3.7% | 1,175,000 | 0.0% | 0.61% | -4.7% | |
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $17,046,000 | -30.6% | 2,014,858 | 0.0% | 0.60% | -31.4% | |
| CDAK | CODIAK BIOSCIENCES INC | $16,821,000 | -11.9% | 1,030,065 | 0.0% | 0.59% | -12.8% | |
| SBTX | SILVERBACK THERAPEUTICS INC | $16,720,000 | -67.7% | 1,675,377 | 0.0% | 0.58% | -68.0% | |
| ODT | ODONATE THERAPEUTICS INC | $16,317,000 | -16.6% | 5,607,086 | 0.0% | 0.57% | -17.4% | |
| MIST | MILESTONE PHARMACEUTICALS INC | $14,687,000 | +3.8% | 2,572,194 | 0.0% | 0.51% | +2.8% | |
| BCEL | ATRECA INC | $13,721,000 | -26.9% | 2,202,333 | 0.0% | 0.48% | -27.6% | |
| SELB | SELECTA BIOSCIENCES INC | $13,662,000 | -0.5% | 3,284,072 | 0.0% | 0.48% | -1.4% | |
| XENE | XENON PHARMACEUTICALS INC | $13,095,000 | -17.9% | 857,000 | 0.0% | 0.46% | -18.8% | |
| FSTX | F-STAR THERAPEUTICS INC | $12,820,000 | -14.8% | 1,751,428 | 0.0% | 0.45% | -15.6% | |
| ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $11,966,000 | -20.4% | 1,536,016 | 0.0% | 0.42% | -21.3% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $10,853,000 | -21.7% | 1,501,058 | 0.0% | 0.38% | -22.5% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $10,510,000 | +6.6% | 500,000 | 0.0% | 0.37% | +5.5% | |
| ELEV | ELEVATION ONCOLOGY INC | $10,451,000 | -42.6% | 1,341,530 | 0.0% | 0.36% | -43.1% | |
| TLIS | TALIS BIOMEDICAL CORP | $9,694,000 | -43.3% | 1,550,998 | 0.0% | 0.34% | -43.9% | |
| IMMP | IMMUTEP LTDsponsored ads | $9,675,000 | 0.0% | 2,500,000 | 0.0% | 0.34% | -0.9% | |
| New | ERASCA INC | $9,549,000 | – | 450,000 | +100.0% | 0.33% | – | |
| SLDB | Sell | SOLID BIOSCIENCES INC | $8,926,000 | -42.4% | 3,734,574 | -11.8% | 0.31% | -43.0% |
| MEIP | MEI PHARMA INC | $8,040,000 | -3.2% | 2,913,091 | 0.0% | 0.28% | -4.1% | |
| VINC | VINCERX PHARMA INC | $7,277,000 | +24.5% | 450,000 | 0.0% | 0.25% | +23.3% | |
| EPIX | ESSA PHARMA INC | $5,496,000 | -72.0% | 687,000 | 0.0% | 0.19% | -72.3% | |
| GMTX | GEMINI THERAPEUTICS INC | $5,252,000 | -37.6% | 1,300,000 | 0.0% | 0.18% | -38.4% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $5,220,000 | -10.3% | 1,500,000 | 0.0% | 0.18% | -11.2% | |
| BLSA | BCLS ACQUISITION CORP | $4,980,000 | -5.4% | 500,000 | 0.0% | 0.17% | -6.5% | |
| RACB | RESEARCH ALLIANCE CORP II | $4,925,000 | -2.9% | 500,000 | 0.0% | 0.17% | -3.9% | |
| PANA | PANACEA ACQUISITION CORP II | $4,885,000 | -2.5% | 500,000 | 0.0% | 0.17% | -3.4% | |
| JYAC | JIYA ACQUISITION CORP | $4,875,000 | -1.9% | 500,000 | 0.0% | 0.17% | -2.9% | |
| NAUT | NAUTILUS BIOTECHNOLOGY INC | $4,605,000 | -39.2% | 750,000 | 0.0% | 0.16% | -39.7% | |
| ORIC | ORIC PHARMACEUTICALS INC | $4,182,000 | +18.2% | 200,000 | 0.0% | 0.15% | +16.8% | |
| HLXA | HELIX ACQUISITION CORP | $3,980,000 | -3.7% | 400,000 | 0.0% | 0.14% | -4.8% | |
| HSAQ | HEALTH SCIENCES ACQ CORP 2 | $3,956,000 | -3.0% | 400,000 | 0.0% | 0.14% | -4.2% | |
| LJPC | LA JOLLA PHARMACEUTICAL CO | $3,554,000 | -6.8% | 890,700 | 0.0% | 0.12% | -7.5% | |
| KNSA | KINIKSA PHARMACEUTICALS LTD | $3,310,000 | -18.2% | 290,577 | 0.0% | 0.12% | -18.9% | |
| LABD | New | DIREXION SHS ETF TRdaily s&p biotec | $3,195,000 | – | 150,000 | +100.0% | 0.11% | – |
| GNCA | GENOCEA BIOSCIENCES INC | $2,178,000 | -18.0% | 1,134,453 | 0.0% | 0.08% | -19.1% | |
| OMEG | OMEGA ALPHA SPACcl a | $1,947,000 | -2.2% | 200,000 | 0.0% | 0.07% | -2.9% | |
| LSAQ | LIFESCI ACQUISITION II CORP | $1,960,000 | -2.0% | 200,000 | 0.0% | 0.07% | -4.2% | |
| TARA | PROTARA THERAPEUTICS INC | $1,448,000 | -28.9% | 209,227 | 0.0% | 0.05% | -29.2% | |
| New | SURROZEN INC | $1,416,000 | – | 200,000 | +100.0% | 0.05% | – | |
| CLRB | CELLECTAR BIOSCIENCES INC | $851,000 | -22.3% | 920,000 | 0.0% | 0.03% | -23.1% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $683,000 | -1.4% | 266,666 | 0.0% | 0.02% | 0.0% | |
| New | MODERNA INCput | $253,000 | – | 10,000 | +100.0% | 0.01% | – | |
| ZGNX | Exit | Zogenix Inc. | $0 | – | -27,300 | -100.0% | -0.02% | – |
| BOLT | Exit | Bolt Biotherapeutics Inc. | $0 | – | -50,000 | -100.0% | -0.03% | – |
| CHFWU | Exit | Consonance HFW Acquisition Corpunit 99/99/9999 | $0 | – | -200,000 | -100.0% | -0.07% | – |
| Exit | Catabasis Pharmaceuticals Inc. | $0 | – | -1,775,000 | -100.0% | -0.13% | – | |
| AGLE | Exit | Aeglea Biotherapeutics Inc. | $0 | – | -550,000 | -100.0% | -0.14% | – |
| MIRM | Exit | Mirum Pharmaceuticals Inc. | $0 | – | -317,000 | -100.0% | -0.19% | – |
| QURE | Exit | UniQure NV | $0 | – | -250,000 | -100.0% | -0.27% | – |
| MTNB | Exit | Matinas Biopharma Holdings Inc. | $0 | – | -11,478,634 | -100.0% | -0.31% | – |
| ESPR | Exit | Esperion Therapeutics Inc. | $0 | – | -500,000 | -100.0% | -0.37% | – |
| IMVT | Exit | Immunovant Inc. | $0 | – | -1,000,000 | -100.0% | -0.37% | – |
| PSTX | Exit | Poseida Therapeutics Inc. | $0 | – | -1,251,055 | -100.0% | -0.44% | – |
| CBAY | Exit | Cymabay Therapeutics Inc. | $0 | – | -4,000,000 | -100.0% | -0.62% | – |
| CERE | Exit | Cerevel Therapeutics Holding Inc. | $0 | – | -714,500 | -100.0% | -0.65% | – |
| MREO | Exit | Mereo Biopharma Group PLCads | $0 | – | -6,226,673 | -100.0% | -0.70% | – |
| BMRN | Exit | Biomarin Pharmaceutical Inc. | $0 | – | -250,000 | -100.0% | -0.74% | – |
| AGEN | Exit | Agenus Inc. | $0 | – | -4,000,000 | -100.0% | -0.78% | – |
| KDMN | Exit | Kadmon Holdings Inc. | $0 | – | -6,205,882 | -100.0% | -0.85% | – |
| RACA | Exit | Therapeutics Acquisition Corp | $0 | – | -2,500,000 | -100.0% | -0.91% | – |
| AMRN | Exit | Amarin Corp PLCspons adr new | $0 | – | -6,000,000 | -100.0% | -0.93% | – |
| SGEN | Exit | Seagen Inc. | $0 | – | -400,000 | -100.0% | -2.23% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 32 | Q3 2023 | 55.2% |
| BEIGENE LTD | 31 | Q3 2023 | 15.6% |
| KURA ONCOLOGY INC. | 24 | Q3 2021 | 4.7% |
| ROCKET PHARMACEUTICALS INC | 23 | Q3 2023 | 5.4% |
| DBV TECHNOLOGIES S A | 23 | Q3 2023 | 3.9% |
| MEI PHARMA INC | 21 | Q2 2023 | 1.4% |
| SYNDAX PHARMACEUTICALS INC | 20 | Q3 2021 | 3.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 4.7% |
| ODONATE THERAPEUTICS INC | 18 | Q1 2022 | 12.5% |
| ESPERION THERAPEUTICS INC NE | 18 | Q2 2021 | 11.0% |
View Boxer Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| IDEAYA Biosciences, Inc. | February 14, 2023 | 2,202,812 | 4.6% |
| Milestone Pharmaceuticals Inc. | February 14, 2023 | 698,861 | 2.0% |
| SpringWorks Therapeutics, Inc. | September 19, 2022 | 3,421,541 | 5.7% |
| iTeos Therapeutics, Inc. | May 11, 2022 | 2,154,058 | 6.1% |
| Atreca, Inc. | February 14, 2022 | 2,202,333 | 7.2% |
| Biomea Fusion, Inc. | February 14, 2022 | 1,188,405 | 4.1% |
| Cabaletta Bio, Inc. | February 14, 2022 | 540,000 | 1.9% |
| CymaBay Therapeutics, Inc. | February 14, 2022 | ? | ? |
| DBV Technologies S.A. | February 14, 2022 | 1,067,299 | 1.9% |
| Elevation Oncology, Inc. | February 14, 2022 | 872,780 | 3.8% |
View Boxer Capital, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-12 |
| 4 | 2024-02-08 |
| SC 13D/A | 2024-02-08 |
| 4 | 2024-01-25 |
| SC 13D/A | 2024-01-25 |
| SC 13G | 2024-01-18 |
| SC 13D/A | 2023-12-18 |
View Boxer Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.